Preparation and properties of metabolically 3H- or 13C-labeled (1 → 3)-β-d-glucan, SSG, from Sclerotinia sclerotiorum IFO 9395

This publication has 20 references indexed in Scilit:

• Effect of intraperitoneally administered .BETA.-1,3-glucan, SSG, obtained from Sclerotinia sclerotiorum IFO 9395 on the functions of murine alveolar macrophages.
  CHEMICAL & PHARMACEUTICAL BULLETIN, 1991
• Preparation and antitumor activity of hydroxyethylated derivatives of 6-branched (1.RAR.3)-.BETA.-D-glucan, SSG, obtained from the culture filtrate of Sclerotinia sclerotiorum IFO 9395.
  CHEMICAL & PHARMACEUTICAL BULLETIN, 1990
• Enhancement of hematopoietic response of mice by intraperitoneal administration of a .BETA.-glucan, SSG, obtained from Sclerotinia sclerotiorum.
  Journal of Pharmacobio-Dynamics, 1990
• Physicochemical properties and antitumor activities of chemically modified derivatives of antitumor glucan "grifolan LE" from Grifola frondosa.
  CHEMICAL & PHARMACEUTICAL BULLETIN, 1989
• Physicochemical properties and antitumor activities of carboxymethylated derivatives of glucan from Sclerotinia sclerotiorum.
  CHEMICAL & PHARMACEUTICAL BULLETIN, 1988
• The effects of a highly branched .BETA.-1,3-glucan, SSG, obtained from Sclerotinia sclerotiorum IFO 9395 on the growth of syngeneic tumors in mice.
  Journal of Pharmacobio-Dynamics, 1988
• Distribution of grifolan NMF-5N (I/B), a chemically modified antitumor .BETA.-glucan in mice.
  Journal of Pharmacobio-Dynamics, 1988
• Conformational changes of the two different conformers of grifolan in sodium hydroxide, urea or dimethylsulfoxide solution.
  CHEMICAL & PHARMACEUTICAL BULLETIN, 1987
• Antitumor activity of a highly branched (1.RAR.3)-.BETA.-D-glucan, SSG, obtained from Sclerotinia sclerotiorum IFO 9395.
  Journal of Pharmacobio-Dynamics, 1987
• Structure and antitumor activity of a .BETA.-1,3-glucan isolated from the culture filtrate of Sclerotinia sclerotiorum IFO 9395.
  CHEMICAL & PHARMACEUTICAL BULLETIN, 1986